Xtant Medical Holdings Inc (XTNT) has disclosed a new risk, in the Capital Markets category.
Xtant Medical Holdings Inc. faces significant business risk due to its exposure to foreign currency exchange rate fluctuations, particularly involving the Euro, Swiss franc, and British pound against the U.S. dollar. Given that the company’s foreign operations use local currencies as their functional currency, earnings are susceptible to volatility from currency exchange movements. Unfavorable shifts in exchange rates could lead to reduced earnings and would manifest as foreign currency translation adjustments in Xtant’s financial statements. The company currently opts not to hedge against this foreign currency exchange rate risk, accepting the inherent financial exposure.
Overall, Wall Street has a Moderate Buy consensus rating on XTNT stock based on 1 Buy.
To learn more about Xtant Medical Holdings Inc’s risk factors, click here.
